In 2024, the FDA approved resmetirom (Rezdiffra) for adults with noncirrhotic NASH with F2F3 fibrosis, marking the first approved pharmacotherapy specifically for this condition
GLP1-RAs are commonly used as a weight loss drug and side effects may include gastrointestinal issues such as nausea, vomiting, diarrhea, constipation and abdominal pain
Several new Jupiter datasets have come from both the Hubble Space Telescope and the New Horizons spacecraft
Despite its promising potential, limited high-quality donor hepatocytes and poor engraftment and repopulation hinder large-scale clinical use
In addition to TET enzymes, VitC enhances the activity of Jumonji C (JmjC) domain-containing histone demethylases (JHDM) and thereby hinders the aberrant self-renewal of hematopoietic stem cells [3]
If you have sleep apnea, heart disease, or prediabetes, coverage is often much easier to obtain